Free Trial

Life Science REIT (LABS) Competitors

Life Science REIT logo
GBX 44.20 +0.20 (+0.45%)
As of 12:01 PM Eastern

LABS vs. THRL, IHR, MXF, AGR, PHP, HWG, PRSR, MLI, WHR, and RDI

Should you be buying Life Science REIT stock or one of its competitors? The main competitors of Life Science REIT include Target Healthcare REIT (THRL), Impact Healthcare REIT (IHR), Medicx Fund (MXF), Assura (AGR), Primary Health Properties (PHP), Harworth Group (HWG), Prs Reit (PRSR), Industrials REIT (MLI), Warehouse REIT (WHR), and Rdi Reit (RDI). These companies are all part of the "real estate" sector.

Life Science REIT vs. Its Competitors

Target Healthcare REIT (LON:THRL) and Life Science REIT (LON:LABS) are both small-cap real estate companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, valuation, dividends, institutional ownership, media sentiment, profitability and risk.

Target Healthcare REIT has a beta of 0.44, meaning that its share price is 56% less volatile than the S&P 500. Comparatively, Life Science REIT has a beta of 0.08, meaning that its share price is 92% less volatile than the S&P 500.

Target Healthcare REIT has a net margin of 104.99% compared to Life Science REIT's net margin of -198.99%. Target Healthcare REIT's return on equity of 10.78% beat Life Science REIT's return on equity.

Company Net Margins Return on Equity Return on Assets
Target Healthcare REIT104.99% 10.78% 3.86%
Life Science REIT -198.99%-14.53%1.25%

Life Science REIT has a consensus target price of GBX 46.50, indicating a potential upside of 5.20%. Given Life Science REIT's stronger consensus rating and higher possible upside, analysts plainly believe Life Science REIT is more favorable than Target Healthcare REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Target Healthcare REIT
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Life Science REIT
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

In the previous week, Target Healthcare REIT had 1 more articles in the media than Life Science REIT. MarketBeat recorded 1 mentions for Target Healthcare REIT and 0 mentions for Life Science REIT. Target Healthcare REIT's average media sentiment score of 0.20 beat Life Science REIT's score of 0.00 indicating that Target Healthcare REIT is being referred to more favorably in the media.

Company Overall Sentiment
Target Healthcare REIT Neutral
Life Science REIT Neutral

Target Healthcare REIT pays an annual dividend of GBX 6 per share and has a dividend yield of 5.8%. Life Science REIT pays an annual dividend of GBX 2 per share and has a dividend yield of 4.5%. Target Healthcare REIT pays out 50.3% of its earnings in the form of a dividend. Life Science REIT pays out -17.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Target Healthcare REIT has higher revenue and earnings than Life Science REIT. Life Science REIT is trading at a lower price-to-earnings ratio than Target Healthcare REIT, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Target Healthcare REIT£68.64M9.15£72.07M£11.938.60
Life Science REIT£20.41M7.69-£40.62M-£11.28-3.92

69.4% of Target Healthcare REIT shares are owned by institutional investors. Comparatively, 67.3% of Life Science REIT shares are owned by institutional investors. 0.1% of Target Healthcare REIT shares are owned by company insiders. Comparatively, 7.0% of Life Science REIT shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Target Healthcare REIT beats Life Science REIT on 13 of the 18 factors compared between the two stocks.

Get Life Science REIT News Delivered to You Automatically

Sign up to receive the latest news and ratings for LABS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LABS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LABS vs. The Competition

MetricLife Science REITREIT IndustryReal Estate SectorLON Exchange
Market Cap£156.92M£1.66B£1.60B£2.96B
Dividend Yield5.67%7.52%6.26%5.02%
P/E Ratio-3.921.4310.41147.41
Price / Sales7.69547.591,254.59240,143.56
Price / CashN/A49.2266.7927.97
Price / Book0.581.451.314.55
Net Income-£40.62M-£74.43M-£120.13M£5.90B
7 Day Performance-3.07%-0.50%0.30%1.27%
1 Month Performance4.00%3.33%2.56%4.62%
1 Year Performance29.24%18.79%13.25%82.58%

Life Science REIT Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LABS
Life Science REIT
N/AGBX 44.20
+0.5%
GBX 46.50
+5.2%
+28.7%£156.92M£20.41M-3.92N/A
THRL
Target Healthcare REIT
N/AGBX 102.20
+1.0%
N/A+23.3%£625.57M£68.64M8.57N/A
IHR
Impact Healthcare REIT
N/AN/AN/AN/A£361.75M£53.51M793.64N/A
MXF
Medicx Fund
N/AN/AN/AN/A£0.00N/A0.00N/AHigh Trading Volume
AGR
Assura
1.2386 of 5 stars
GBX 50.22
+0.3%
GBX 51
+1.6%
+18.5%£1.64B£188.76M-48.0084
PHP
Primary Health Properties
1.8757 of 5 stars
GBX 96.95
-0.8%
GBX 107.50
+10.9%
+2.4%£1.30B£178.59M-151.3458High Trading Volume
HWG
Harworth Group
N/AGBX 185.50
+0.5%
N/A+17.8%£610.70M£97.22M12.23120Positive News
High Trading Volume
PRSR
Prs Reit
3.3279 of 5 stars
GBX 107
+0.4%
GBX 120
+12.1%
+38.0%£585.62M£58.11M6.252Gap Up
MLI
Industrials REIT
N/AN/AN/AN/A£494.79M£50.19M1,050.005,140
WHR
Warehouse REIT
N/AGBX 112.40
-1.2%
N/A+35.6%£476.15M£50.81M1.0961,000
RDI
Rdi Reit
N/AN/AN/AN/A£462.34M£68.40M-4.442,020

Related Companies and Tools


This page (LON:LABS) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners